Jiangsu Alphamab Biopharmaceuticals Co., Ltd

This study is testing a new combination therapy called JSKN016 for people with advanced non-small cell lung cancer that has spread. The main goals are to see if the treatment is safe and if it helps shrink tumors. Researchers will enroll 288 adults in China who have not had certa…

This study is testing a new drug called JSKN003 against standard chemotherapy for people with advanced HER2-low breast cancer that has spread or returned. It is for adults whose cancer has worsened after trying 1 or 2 prior chemotherapy treatments. The goal is to see if JSKN003 c…

This study is testing whether a new drug called JSKN016, when combined with other cancer treatments, can help control advanced breast cancer that has spread or cannot be removed by surgery. It will involve 180 Chinese adults whose cancer does not respond to the HER2 protein. Rese…

This is the first human study of an experimental cancer drug called JSKN022. It aims to find a safe dose and check for early signs that the drug might help control advanced solid tumors in patients who have run out of standard treatment options. The study will enroll about 225 ad…